盐酸头孢唑兰
| 中文名称 | 盐酸头孢唑兰 |
|---|---|
| 中文同义词 | 盐酸头孢唑兰;头孢唑兰盐酸盐;1-[[(6R,7R)-7-[(Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-甲氧亚氨基乙酰胺基]-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]咪唑并[1,2-b]哒嗪鎓内盐盐酸盐;1-[[(6R,7R)-7-[(Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-甲氧亚氨基乙酰胺基]-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基]甲基]咪唑并[1,2-B]哒嗪内盐盐酸盐;1-(((6R,7R)-7-((Z)-2-(5-氨基-1,2,4-噻二唑-3-基)-2-(甲氧基亚氨基)乙酰胺基)-2-羧基-8-氧代-5-硫杂-1-氮杂双环[4.2.0]辛-2-烯-3-基)甲基)咪唑[1,2-B]哒嗪-1-氯化铵;PERFEMIKER]盐酸头孢唑兰,97% |
| 英文名称 | Cefozopran hydrochloride |
| 英文同义词 | Cefozopran hydrochloride;(6R,7R)-7-[[(2E)-2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-methoxyiminoacetyl]amino]-3-(imidazo[2,3-f]pyridazin-4-ium-1-ylmethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid chloride;Cefozopran hydrochloride (jp15);Czop;D02233;Firstcin (tn);Cefozopran hydrochlo;SCE-2787 hydrochloride |
| CAS号 | 113981-44-5 |
| 分子式 | C19H18ClN9O5S2 |
| 分子量 | 551.98 |
| EINECS号 | 1806241-263-5 |
| 相关类别 | 盐酸头孢唑兰及其中间体;医药原料药;药物杂质及中间体;医药、农药及染料中间体;Cefozopran Hydrochloride and its intermediates |
| Mol文件 | 113981-44-5.mol |
| 结构式 |  |
盐酸头孢唑兰 性质
| 储存条件 | under inert gas (nitrogen or Argon) at 2-8°C |
|---|---|
| 水溶解性 | Water : ≥ 52 mg/mL (94.20 mM) |
Cefozopran (SCE-2787) is a fourth-generation cephalosporin that has good activity against gram-positive organisms including methicillin-susceptible staphylococci, enterococci, and viridans group streptococci; and against gram-negative organisms including hemophilus influenza. Moreover, cefozopran has comparatively good activity against enterococci and P. aeruginosa , which are refractory to other cephalosporins.
Cefozopran (SCE-2787) (5-80 mg/kg; s.c.; twice a day for 5 days; four-week-old ICR male mice) is effective against acute respiratory tract infections caused by Kiebsiella pneumonia DT-S. In the model of chronic respiratory tract infection caused by K. pneumoniae 27, Cefozopran (20-80 mg/kg; s.c.; twice a day for 7 days; five-week-old CBA/J female mice) is as effective as Ceftazidime.